We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+3.63%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.45B
AUM Growth
+$192M
(+4.5%)
Cap. Flow
+$96.4M
Cap. Flow
% of AUM
2.17%
Top 10 Holdings %
Top 10 Hldgs %
37.03%
Holding
3,677
New
275
Increased
1,530
Reduced
993
Closed
158
Avg Time Held Equity + Options
4.4
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
3.6
years
Avg Time Held Equity only
4.4
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
3.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$18.7M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$15.5M |
| 3 |
PIMCO Ultra Short Government Active ETF
BILZ
|
+$6.8M |
| 4 |
JPMorgan Active Bond ETF
JBND
|
+$5.14M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$5.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
|
+$8.95M |
| 2 |
Palantir
PLTR
|
+$7.81M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$5.25M |
| 4 |
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
+$3.68M |
| 5 |
UnitedHealth
UNH
|
+$1.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 16.97% |
| 3 | Healthcare | 8.95% |
| 4 | Financials | 7.08% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3426
Life Time Group Holdings
LTH
$8.88B
| $88 | ﹤0.01% |
+4
| New | +$96 |
2024 Q4
0 quarters
|
|
3427
FTAI Infrastructure
FIP
$267M
| $87 | ﹤0.01% |
+12
| New | +$103 |
2024 Q4
0 quarters
|
|
3428
CG Oncology
CGON
$5.53B
| $86 | ﹤0.01% |
3
-14
| -82% | -$479 |
2024 Q3
1 quarter
|
|
3429
DocGo
DCGO
$25M
| $85 | ﹤0.01% |
+20
| New | +$77 |
2024 Q4
0 quarters
|
|
3430
Vera Therapeutics
VERA
$1.99B
| $85 | ﹤0.01% |
2
-13
| -87% | -$576 |
2024 Q3
1 quarter
|
|
3431
BrightSpring Health Services
BTSG
$12.4B
| $85 | ﹤0.01% |
+5
| New | +$86 |
2024 Q4
0 quarters
|
|
3432
TXO Partners LP
TXO
$786M
| $84 | ﹤0.01% |
5
| – | – |
2024 Q3
1 quarter
|
|
3433
DELISTED
Semrush
SEMR
| $83 | ﹤0.01% |
+7
| New | +$94 |
2024 Q4
0 quarters
|
|
3434
ArriVent BioPharma
AVBP
$812M
| $80 | ﹤0.01% |
+3
| New | +$86 |
2024 Q4
0 quarters
|
|
3435
DELISTED
Nuvalent
NUVL
| $78 | ﹤0.01% |
1
-8
| -89% | -$747 |
2024 Q3
1 quarter
|
|
3436
Texas Capital Bancshares
TCBI
$3.88B
| $78 | ﹤0.01% |
1
| – | – |
2024 Q2
2 quarters
|
|
3437
Editas Medicine
EDIT
$355M
| $76 | ﹤0.01% |
60
| – | – |
2022 Q2
10 quarters
|
|
3438
Cipher Digital
CIFR
$3.78B
| $74 | ﹤0.01% |
+16
| New | +$91 |
2024 Q4
0 quarters
|
|
3439
Renasant Corp
RNST
$3.57B
| $74 | ﹤0.01% |
2
| – | – |
2023 Q4
4 quarters
|
|
3440
AdvisorShares Pure Cannabis ETF
YOLO
$29.1M
| $73 | ﹤0.01% |
30
| – | – |
2023 Q1
7 quarters
|
|
3441
DELISTED
HOOKIPA Pharma
HOOK
| $70 | ﹤0.01% |
35
| – | – |
2024 Q2
2 quarters
|
|
3442
iShares Global Financials ETF
IXG
$696M
| – | – |
0
| – | – |
2024 Q4
0 quarters
|
|
3443
SVRN, Inc. Common Stock
SVRN
$62.1M
| – | – |
0
| – | – |
2023 Q2
6 quarters
|
|
3444
Standard BioTools
LAB
$252M
| $65 | ﹤0.01% |
37
| – | – |
2024 Q1
3 quarters
|
|
3445
ThredUp
TDUP
$301M
| $64 | ﹤0.01% |
46
| – | – |
2023 Q1
7 quarters
|
|
3446
Disc Medicine
IRON
$2.16B
| $63 | ﹤0.01% |
+1
| New | +$58 |
2024 Q4
0 quarters
|
|
3447
Cohen & Steers REIT and Preferred and Income Fund
RNP
$883M
| $63 | ﹤0.01% |
3
| – | – |
2020 Q4
16 quarters
|
|
3448
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$345M
| $63 | ﹤0.01% |
+1
| New | +$62 |
2024 Q4
0 quarters
|
|
3449
Microvast
MVST
$202M
| $62 | ﹤0.01% |
30
| – | – |
2021 Q1
15 quarters
|
|
3450
iShares US Healthcare Providers ETF
IHF
$1.43B
| $61 | ﹤0.01% |
1
-79
| -99% | -$4.17K |
2016 Q4
32 quarters
|
|
Similar funds
Parallel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Parallel Advisors held 3,677 positions worth $4.45B, up 4.5% from $4.25B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q4 2024 filing shows 275 new, 1,530 increased, 993 reduced and 158 closed positions. Its largest new stake was PIMCO Ultra Short Government Active ETF: 67,253 shares worth $6.78M. The largest sale was State Street SPDR Bloomberg 3-12 Month T-Bill ETF, an estimated $8.95M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 48% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q4 2024 buy was PIMCO Ultra Short Government Active ETF: 67,253 shares worth $6.78M.
- Parallel Advisors added most to Crown Castle in Q4 2024, an estimated $18.7M increase.
- Parallel Advisors's biggest Q4 2024 reduction was State Street SPDR Bloomberg 3-12 Month T-Bill ETF, cutting an estimated $8.95M.
- Parallel Advisors fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $3.68M.
- Parallel Advisors's ten largest holdings make up 37% of its $4.45B portfolio in Q4 2024.
- Parallel Advisors opened 275 new positions and closed 158 in Q4 2024.
- Parallel Advisors's portfolio value rose 4.5% quarter-over-quarter to $4.45B.
Based on Parallel Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.